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Abstract
Aims
In a recent genome-wide association study, WD-repeat domain 12 (WDR12) was associat-
ed with early-onset myocardial infarction (MI). However, the function of WDR12 in the heart
is unknown.
Methods and Results
We characterized cardiac expression of WDR12, used adenovirus-mediated WDR12 gene
delivery to examine effects of WDR12 on left ventricular (LV) remodeling, and analyzed re-
lationship between MI associated WDR12 allele and cardiac function in human subjects. LV
WDR12 protein levels were increased in patients with dilated cardiomyopathy and rats
post-infarction. In normal adult rat hearts, WDR12 gene delivery into the anterior wall of the
LV decreased interventricular septum diastolic and systolic thickness and increased the dia-
stolic and systolic diameters of the LV. Moreover, LV ejection fraction (9.1%, P<0.05) and
fractional shortening (12.2%, P<0.05) were declined. The adverse effects of WDR12 gene
delivery on cardiac function were associated with decreased cellular proliferation, activation
of p38 mitogen–activated protein kinase (MAPK)/heat shock protein (HSP) 27 pathway,
and increased protein levels of Block of proliferation 1 (BOP1), essential for ribosome bio-
genesis. Post-infarction WDR12 gene delivery decreased E/A ratio (32%, P<0.05)
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suggesting worsening of diastolic function. In human subjects, MI associated WDR12 allele
was associated significantly with diastolic dysfunction and left atrial size.
Conclusions
WDR12 triggers distinct deterioration of cardiac function in adult rat heart and the MI associ-
ated WDR12 variant is associated with diastolic dysfunction in human subjects.
Introduction
Heart failure (HF) is one of the most common causes of cardiovascular morbidity and mortali-
ty, and its prevalence is rapidly increasing as the mean age of the population advances [1]. Cor-
onary artery disease (CAD) and its main complication, myocardial infarction (MI), is the
leading cause of adverse left ventricular (LV) remodeling and HF [2,3]. Recent genome-wide
association studies (GWAS) have identified several single nucleotide polymorphisms (SNPs) as
reproducibly associated with risk of CAD and MI. In the largest genetic study to date, a total of
46 genomic loci were linked to variation in susceptibility to CAD [4]. Of the 46 genome-wide
significant lead SNPs, 12 showed a significant association with a lipid trait and 5 showed signif-
icant association with blood pressure. One of the strongest associated variants, located at the
WDR12 locus, was initially associated with risk for early-onset MI [5], but its cellular and func-
tional role in the heart is unknown.
WDR proteins contain a series of highly conserved repeat motifs, which typically contains a
tryptophan-aspartic acid dipeptide (the WD unit) at its carboxy terminus and a glycine-histi-
dine dipeptide residues downstream from its amino terminus [6]. More than 160 distinct
members of WDR proteins have been identified and the majority of them are found in eukary-
otes [7]. WDR proteins are associated with several cellular processes such as regulation of sig-
nal transduction, pre-mRNA processing, gene transcription, cell cycle progression and
cytoskeleton organization [6]. Endogenous WDR12 is crucial for processing of the 32S precur-
sor ribosomal RNA (rRNA) and cell proliferation. High levels of WDR12 mRNA are found in
the thymus and testis of adult mice and it is ubiquitously expressed during embryogenesis [8].
A nucleolar complex of endogenous Pescadillo 1 (Pes1), Block of proliferation 1 (BOP1) and
WDR12 is termed as PeBoW complex in mammalian cells, and is essential for ribosome bio-
genesis [9,10].
In the present study, we analyzed the expression of WDR12 in the heart and used WDR12
gene delivery to examine direct functional and structural effects of WDR12 on LV remodeling.
Because these experiments revealed that local WDR12 gene delivery deteriorated systolic and
diastolic function, we evaluated potential mechanisms triggering the impairment of cardiac
function by WDR12 gene overexpression. Furthermore, we analyzed the relationship between
MI associated WDR12 allele and cardiac function, measured by echocardiography, in a cohort
of approximately 1400 human subjects.
Materials and Methods
Ethics Statement
All experimental protocols were approved by the Animal Use and Care Committee of the Uni-
versity of Oulu and the Provincial Government of Western Finland Department of Social
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(TH and BW). The funders had no role in study
design, data collection and analysis, decision to
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Affairs and Health. The investigations conform to the Guiding Principles for Research Involv-
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For human studies, the study complies with the Declaration of Helsinki. The study protocol
was approved by the Internal Review Committee of the University of Semmelweis, Hungary
(Ethical permission number: 5012-0/2011-EKU 142/PI/11–Semmelweis, University; Hungary)
and written informed consent was obtained from the subjects, except that the Institution has
the ethical permission to collect tissue samples from healthy subjects (victims of accidents).
Recombinant Adenovirus Vectors
For constructions of rat WDR12, a full-length coding region of WDR12 cDNA was cloned into
the SalI andHindIII sites of the pShuttle-CMV vector (Qbiogene Inc., Illkirch, Cedex-France).
The sequences for the cloning primers used were as follows; WDR12 forward 5'-GCG TCG
ACC TTT CTG CCA TGG CAC AAC-3' and reverse 5'-CCC AAG CTT TCA AGC CCC CAC
ATG GGA AGT-3'. The pShuttle-CMV-LacZ was a commercial plasmid (Stratagene, La Jolla,
CA, USA). Adenoviruses (serotype 5) were prepared by standard protocols (Qbiogene Inc., Ill-
kirch, Cedex-France) and purified by centrifugation on iodixanol (OptiPrep, Axis-Shield PoC
AS, Oslo, Norway). The adenoviral titers (infectious unit, ifu) were determined by AdEasy
Viral Titer Kit (Stratagene). Infectious unit is biologically equivalent to plaque forming unit
(PFU). β -galactosidase concentration was determined by luminescent β -gal Kit (Clontech
Laboratories Inc., Palo Alto, CA, USA). The recombinant adenoviruses containing the coding
regions of the constitutively active mitogen-activated protein kinase kinases (MKK), MKK3b
and MKK6b and wild type p38α, and p38β genes driven by CMV immediate early promoter
were generated as described previously [11]. In another series of experiments, we have ob-
served that overexpression of p38α and p38β produce similar p38 and phosho-p38-mitogen–
activated protein kinase (MAPK) levels in cardiomyocytes (Kaikkonen et al., unpublished ob-
servation). MKK and p38 adenoviruses were generously supplied by Dr. Veli-Matti Kähäri
from the University of Turku, Finland.
Intramyocardial Gene Transfer
We and others have previously shown that local injection of adenoviral constructs into the left
ventricular free wall is an efficient site-specific method of gene delivery that targets high ex-
pression of the transgene in the LV without affecting other organs or other regions of the heart
[12,13]. Male Sprague-Dawley rats weighing 250–300 g were anesthetized with medetomidine
hydrochloride (Domitor, 250 μg/kg i.p.) and ketamine hydrochloride (Ketamine, 50 mg/kg i.
p.). Rats were connected to the respirator through a tracheotomy. A left thoracotomy and peri-
cardial incision was performed. Adenovirus-mediated gene transfer into the LV free wall was
performed as previously described [13,14]. Different doses of adenoviral constructs were first
tested to increase LVWDR12 protein levels. Then, recombinant adenovirus (4 x 109 ifu), in a
100 μl volume, was injected using a Hamilton precision syringe directly into the anterior wall
of the LV. The syringe was inserted in one site of the LV free wall (apex to base), and then slow-
ly the solution was injected while withdrawing the syringe. After the operation, anaesthesia was
partially antagonized with atipamezole hydrochloride (Antisedan, 1.5 mg/kg i.p.) and rats were
hydrated with physiological saline solution (5 ml s.c.). For postoperative analgesia, buprenor-
phine hydrochloride (Vetergesic, 0.05–0.2 mg/kg s.c.) was administered. The total number of
animals used was 240.
WRD12 and Cardiac Function
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Acute Myocardial Infarction
MI was produced by ligation of the left anterior descending coronary artery (LAD) as previous-
ly described [13,15]. The sham-operated rats underwent the same surgical procedure without
the ligation of LAD. Recombinant adenovirus was injected into the anterior wall of the LV be-
fore the ligation of LAD. The adenoviral gene delivery to the sham-operated hearts was per-
formed using the same technique without the ligation of LAD.
Angiotensin II-Mediated Hypertension
Angiotensin II (Ang II, 33.3 μg/kg/h) (a generous gift from Dr. Olli Vuolteenaho, University of
Oulu, Finland), was administered via subcutaneously implanted osmotic minipumps for 6
hours and 2 weeks (Alzet, Scanbur BK AB, Sollentuna, Sweden), as described previously
[16,17]. Minipumps were implanted subcutaneously before the gene delivery. Ang II–mediated
hypertension has been used extensively in key studies in the development of antihypertensive
agents [18–21]. Using this experimental model of hypertension, mean arterial pressure in-
creases rapidly (within 3 hours) and remains significantly elevated throughout the 2-weeks pe-
riod [16]. Under our experimental conditions, Ang II type 1 receptor (AT1-R) blockade by
losartan completely abolished Ang II–induced changes in the cardiac gene expression, left ven-
tricular weight to body weight ratio and hemodynamics [17].
Echocardiographic Measurements
Transthoracic echocardiography was performed using the Acuson Ultrasound System (Sequoia
512) and a 15-MHz linear transducer (15L8) (Acuson, MountainView, CA, USA) as previously
described [13,22]. Before examination, rats were sedated with ketamine (50 mg/kg i.p.) and
xylazine (10 mg/kg i.p.). Using two-dimensional imaging, a short axis view of the LV at the
level of the papillary muscles was obtained, and a two dimensionally guided M-mode recording
through the anterior and posterior walls of the LV was obtained. LV end-systolic and end-dia-
stolic dimensions as well as the thickness of the interventricular septum and posterior wall
were measured from the M-mode tracings. LV fractional shortening (FS) and ejection fraction
(LVEF) were calculated from the M-mode LV dimensions using the Eqs 1 and 2:
FS ð%Þ ¼ ðLVEDD LVESDÞ
LVEDD
 
 100 ð1Þ
LVEF ð%Þ ¼ ðLVEDDÞ
3  ðLVESDÞ3
LVEDD3
 
 100 ð2Þ
An average of three measurements of each variable was used. All echocardiographical mea-
surements were performed blinded by persons (E.M. and Z.Sz.), who were not aware of the
treatments. After echocardiography, the animals were sacrificed. Hearts were weighed and the
ventricles were immersed in liquid nitrogen and stored at—70°C for later analysis.
Extraction of Cytoplasmic Protein andWestern Blot Analyses
To extract the cytoplasmic protein, the left ventricular tissue was broken and reduced to a pow-
der in liquid nitrogen. The thawed powder was homogenized in a lysis buffer (20 mmol/l Tris-
HCl (pH 7.5), 10 mmol/l NaCl, 0.1 mmol/l EDTA, 0.1 mmol/l EGTA, 1 mmol/l β-glyceropho-
sphate, 1 mmol/l Na3VO4, 2 mmol/l benzamidine, 1 mmol/l phenylmethylsulfoxide, 50 mmol/
l NaF, 1 mmol/l dithiothreitol and 10 μg/ml each of leupeptin, pepstatin and aprotinin). The
cytosolic fraction was separated out by centrifugation at 2000 rpm in +4°C for 1 minute. To
WRD12 and Cardiac Function
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separate the cytoplasmic protein fraction, 5 x nuclear extraction buffer (NEB) (100 mM Tris-
HCl (pH 7.5), 750 mMNaCl, 5 mM EDTA, 5 mM EGTA, 5% Triton X 100, 12 mM sodium py-
rophosphate, 5 mM β-glycerophosphate, 5 mM Na3VO4) was added to the tissue homogenate
following by centrifugation at 12500 rpm in +4°C for 20 minutes. The supernatant was frozen
in liquid nitrogen and stored in—70°C until assayed.
To extract the nuclear protein fraction, the supernatant from the first centrifugation was in-
cubated on ice for 15 minutes, NP-40 was added, and the nuclei were collected by centrifuga-
tion at 12500 rpm for 30 seconds. The pellet was resuspended in a solution containing 20 mM
HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1mM EGTA, 1 mMNa3VO4, 2 mM benzamidine,
1 mM PMSF, 50 mMNaF, 1 mMDTT, 3 μg/ml 1-chloro-3-tosylamido-7-phenyl-2-butanone
(TPCK), 3 μg/ml L-1-tosylamido-2-phenylethyl chloromethyl ketone (TLCK), and 10 μg/ml
each of leupeptin, pepstatin and aprotinin. The samples were incubated at +4°C for 30 minutes,
centrifuged at 12500 rpm for 5 minutes and the resulting supernatants frozen in liquid nitrogen
and stored in—70°C until assayed. All protein concentrations were determined by Bio-Rad
protein assay.
In the western blot analysis, 30 μg total protein or nuclear protein was subjected to
SDS-PAGE and the separated proteins were electrically transferred to Optitran BA-S 85 nitro-
cellulose membranes (Scleicher & Schuell BioScience, Dassel, Germany). After blocking the
nonspecific background in a mixture (1:1) of Odyssey Blocking Buffer—Tris–buffered saline
(TBS), nitrocellulose membranes were incubated with appropriate primary antibody in Odys-
sey Blocking Buffer–TBS overnight at +4°C. Nitrocellulose membranes were incubated with
antiphospho-p38-MAPK, antiphospho-ERK1/2, antisarcoplasmic reticulum Ca2+-ATPase
(SERCA2), anti-p38-MAPK or anti-ERK1/2, anti-WDR12, anti-BOP1, anti-Pescadillo, anti-
phospho-heat shock protein 27 (HSP27), anti-HSP27, anti-Lamin B and anti-GAPDH-anti-
body. The antibody dilution varied from 1:200 to 1:2000, depending on the signal strength.
After washing, antibody binding was detected with specific secondary antibodies, fluorescent
(Alexa Fluor) antibodies (1:3000–1:5000) used with Odyssey Infrared Imaging System.
For a second western blot, the membranes were stripped in buffer containing 62.5 mmol/l
tris (pH 6.8), 2% sodium dodecyl sulfate, and 100 mmol/l mercapthoethanol. The detection
was based on fluorescence measured by the Odyssey Infrared Imaging System. The bands were
scanned and analyzed with Quantity One software (Bio-Rad Laboratories, Hercules, CA,
USA). Antibodies were obtained from Millipore (Temecula, CA, USA), Invitrogen (Carlsbad,
CA, USA), Aviva systems biology (San Diego, CA, USA), Santa Cruz Biotechnology (CA,
USA) and Cell Signaling Technology (Beverly, MA, USA).
Isolation and Analysis of RNA
The RNA was extracted from the left ventricular tissue by using the guanidine-thiocyanate-
CsCl method [23]. Cyclin-dependent kinase 4 inhibitor 2c (Cdkn2c), p19ARFexon1b,
p16INK4a, cyclin-dependent kinase 4 inhibitor 2b (Cdkn2b), tropomyosin 1, WDR12, fibro-
nectin-1 and 18S mRNA levels were analyzed by the RT-PCR using TaqMan chemistry on an
ABI 7300 Sequence Detection System (Applied Biosystems) as previously described [24–26].
The sequences of the forward and reverse primers and for fluorogenic probes for RNA detec-
tion are shown in Table 1. The results were normalized to 18S RNA quantified from the
same samples.
Histology, Immunohistochemistry and Image Analysis
For histological analysis, the LVs were fixed in 10% buffered formalin solution. Transversal
sections of the LV were embedded in paraffin, and 5-μm sections were cut. Sections were cut
WRD12 and Cardiac Function
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from the mid-section of the heart, at the level of the papillary muscles. Samples from different
animals were obtained in an identical way and from the corresponding sites in order to make
the samples fully comparable. Sections were stained with hematoxylin and eosin or Massons's
trichrome to examine the fibrotic area of the LV. Previously we have studied the local response
to adenovirus-mediated gene transfer by measuring the fibrotic area in the LV at 2 weeks after
intramyocardial injection of adenoviral construct expressing LacZ and PBS-based buffer (3%-
iodixanol-PBS) as well as from the hearts with needle-stick (no injection of fluid) and non-in-
jected hearts. The results demonstrated that the degree of fibrosis did not differ between PBS-
based buffer- and LacZ-injected hearts, but tended to be higher in these groups than in non-in-
jected hearts [27].
Pecam-1 (sc-1506-R, Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used to stain en-
dothelial cells. The number of capillaries was calculated from five representative high power
Table 1. Forward and reverse primer and fluorogenic probe sequences used for real time quantitative RT-PCR analysis.
Gene Sequence
BNP Forward TGGGCAGAAGATAGACCGGA
Reverse ACAACCTCAGCCCGTCACAG
Fluorogenic probe CGGCGCAGTCAGTCGCTTGG
ANP Forward GAAAAGCAAACTGAGGGCTCTG
Reverse CCTACCCCCGAAGCAGCT
Fluorogenic probe TCGCTGGCCCTCGGAGCCT
Fibronectin-1 Forward GCGAGGCAGGATCAGCTG
Reverse CCAATCTTGTAGGACTGACCCC
Fluorogenic probe ACCATTGCAAATCGCTGCCATGAA
Tpm1 Forward GAAAGCCGAGCCCAAAAAG
Reverse GCTTACGGGCCACCTCTTC
Fluorogenic probe TCCAGCTGAAAGAGGCCAAGCACATT
p19ARFexon1b Forward GGTGCAGTTCCTGGGATCCT
Reverse TCAACACCAAGGCCACGAA
Fluorogenic probe CGACCCAGGTCAGCGAACGGC
p16INK4a Forward TCCTCCGCTGGGAACGT
Reverse GGCGTGCTTGAGCAGAAGTT
Fluorogenic probe TCCCGGGTCACCGACAGGCA
Cdkn2b Forward CCCTCACCAGACCTGTGCAT
Reverse CAGGCGTCACACACATCCA
Fluorogenic probe CTTCCTGGACACGCTAATGGTGCTGC
Cdkn2c Forward GAGGTGCTAATCCCAATTTGAAA
Reverse AGCCTGTACAGTGTCCAGGAAAC
Fluorogenic probe ACCGAACTGGTTTTGCTGTCATTCACG
WDR12 Forward TGGCTTGGGTGAAAAAAGACA
Reverse TCCCATAAGAGAATAGTCTGGTCCAT
Fluorogenic probe TCTGTCTTGCCTACTCCTGACGGCCTC
18S Forward TGGTTGCAAAGCTGAAACTTAAAG
Reverse AGTCAAATTAAGCCGCAGGC
Fluorogenic probe CCTGGTGGTGCCCTTCCGTCA
BNP, B-type natriuretic peptide; ANP, atrial natriuretic peptide; Cdkn2b, cyclin-dependent kinase 4 inhibitor 2b; Cdkn2c, cyclin-dependent kinase 4
inhibitor 2c; Tpm1, Tropomyosin 1; WDR12, WD-repeat domain 12; TGFβ1, transforming growth factor β1; RT-PCR, real time quantitative reverse
transcription-PCR.
doi:10.1371/journal.pone.0124907.t001
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fields (40×) from the LV of each section; 3 from epicardial and 2 from endocardial side of the
LV were selected. To detect apoptotic cells, in situ labeling of the 3'-ends of the DNA fragments
generated by apoptosis-associated endonucleases was performed using the ApopTag in situ ap-
optosis detection kit (Chemicon, Temicula, CA, USA), as previously described [28]. Briefly,
DNA fragmentation was identified by applying terminal transferase enzyme with digoxigenin-
labeled nucleotides. Anti-digoxigenin antibody was used to recognize the digoxigenin-labeled
nucleotide chains attached to the 3'-ends of sample DNA. A color reaction was produced with
diaminobenzidine and the sections were counterstained with hematoxylin. The apoptotic cells
and bodies were counted in 5 high power fields (40× objective) choosing hot spot areas in each
sample in order to make the results comparable. To determine whether TUNEL positive cells
and proliferating cells were cardiomyocytes, cardiac fibroblasts or endothelial cells, immuno-
fluorescence stainings were performed with alpha-actinin (ab28052, Abcam Inc., Cambridge,
MA, USA), anti-prolyl 4-hydroxylase β (MAB2073, Millipore, Temecula,CA, USA) or Pecam-
1 (sc-1506-R, Santa Cruz Biotechnology), respectively, and DAPI (diamidinophenylindole
dihydrochloride, Sigma-Aldrich, St. Louis, MO, USA) as a nuclear stain.
To examine the efficiency and localization of the WDR12 gene delivery, the sections were
incubated with specific polyclonal anti-WDR12 antibody (sc-132875, Santa Cruz Biotechnolo-
gy, Santa Cruz, CA, USA) at the dilution of 1:50 3 days after gene transfer. Primary antibody
for c-kit (sc-168, Santa Cruz Biotechnology, CA, USA) was used to stain stem cells. The num-
ber of c-kit+ cells in the anterior wall of LV was counted. The area of counted section was ex-
amined by computerized methods and a number of positively staining cells was related to the
area (cells/35 mm2). To identify cells undergoing division, immunohistochemical labeling of
nuclear Ki-67 or Phospho-histone-H3 antigen was performed by using monoclonal mouse
anti-rat Ki-67 antigen antibody (DakoCytomation, Glostrup, Denmark) or Phospho-histone-
H3 antigen antibody (Cell Signaling Technology, Beverly, MA, USA). The whole LV was
scanned and stained cells were counted from high power fields (40×) choosing 5 hot spot areas
in each sample. The primary antibodies were detected by peroxidase conjugated EnVision De-
tection Kit system (DakoCytomation, Denmark) and the samples were counterstained with
haematoxylin. All measurements were performed blinded by persons, who were not aware of
the treatments.
Cell Culture
Neonatal rat ventricular myocytes were prepared from 2- to 4-day-old Spraque-Dawley rats as
described earlier [29]. WDR12 or LacZ-adenoviruses were added to the cell culture medium
24h after the cells were plated and incubated 24h, at the virus concentration 6 MOI. The media
were replaced every 24h, and 48h after infection, the cells were washed twice with PBS and
quickly frozen at −70°C. For mechanical stretch experiments cardiomyocytes were plated on
Bioflex plates and exposed to cyclic mechanical stretch as previously described [30]. Mechani-
cal stretch was applied by Flexercell strain unit FX-5000. Adenoviral gene transfer of p38α and
p38β as well as WDR12 in neonatal cardiomyocytes was performed as described previously
[31].
Cardiac fibroblasts were separated from myocytes and plated on 10-cm dishes. On reaching
confluences, fibroblasts were passaged into 6- or 12-well plates (170,000 or 70,000 cells/well, re-
spectively). Specific siRNAs (WDR12 siRNA1 5’-GGGCCAGUUUCUUCGAAUGtt-3’ and
WDR12 siRNA2 5’-GGAAAUAAGGUGUUCAAUUtt-3’) from Ambion, and negative control
siRNA (mixed Ambion and Sigma-Aldrich) were transfected into the cardiomyocytes or cardi-
ac fibroblasts using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) as transfection
WRD12 and Cardiac Function
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reagent. Cells were incubated in OPTI-mem (Invitrogen, Carlsbad, CA, USA) for 24h and
thereafter cells were incubated in CSFM (myocytes) or DMEM+10% FBS (fibroblasts).
Total RNA was isolated from cell culture neonatal rat ventricular myocytes with TRIzol re-
agent (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s protocol by using the
Phase Lock Gel system (Eppendorf AG, Hamburg, Germany). Cultured cardiomyocytes were
lysed in ice-cold lysis buffer (20 mM Tris-HCl, 150 mMNaCl, 1 mM EDTA, 1 mM EGTA, 1%
Triton-X100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mMNa3VO4) sup-
plemented with protease-inhibitor cocktail, phosphatase-inhibitor cocktail and 1mMDTT.
The lysate was vortexed and then cleared by centrifugation at +4°C. The supernatant was then
transferred in a new tube as the total protein extract.
The nuclear and cytosolic proteins were extracted adapting the protocol described by
Schreiber et al. [32]. Cultured cardiomyocytes were washed and scraped with ice-cold 1x phos-
phate-buffered saline. After centrifugation the cell pellets were resuspended in 100 μl of low
salt buffer consisting of 10 mMHEPES, 10 mM KCl, 0.1 mM EDTA and 0.1 mM EGTA sup-
plemented with protease-inhibitor cocktail, phosphatase-inhibitor cocktail and 1 mM DTT.
The suspensions were then allowed to swell on ice for 15 min. Then, membrane proteins were
solubilised and isolated by adding 10 μl of 10% IGEPAL CA-630 detergent and vortexing vigor-
ously followed by centrifugation. The supernatants were collected as the cytosolic fragments.
The pellets were resuspended of high salt buffer containing 20 mMHEPES, 0.4 M NaCl, 1 mM
EDTA and 1 mM EGTA, with supplements similar to those in low salt buffer and then rocked
for 15 min. The samples were centrifuged and the supernatant was collected as the nuclear
fragment. The entire procedure was carried out +4°C. Protein concentrations were determined
with the Bio-Rad protein assay.
Human LV Tissue Samples
LV samples were obtained from organ donors (n = 2) and patients with end-stage heart failure
due to cardiomyopathy (n = 4) (2 patients were diagnosed with dilated cardiomyopathy, 1 with
hypertrophic cardiomyopathy and 1 with idiopathic cardiomyopathy). The donor subjects had
no cardiac history and no significant structural abnormalities on cardiac donor screening using
echocardiography and coronary angiography. Donors were maintained under intensive care,
but hearts were excluded ultimately from heart implantation because of age, size mismatch or
blood type incompatibilities. After removal, cardiac tissue samples were blotted dry, immersed
in liquid nitrogen, and stored at −80°C until assayed.
All patients were classified according to New York Heart Association (NYHA) functional
classes III and IV. Transthoracic echocardiograms were performed using a 2.5-MHz linear
transducer. Coronary angiographies were performed in all subjects using percutaneous femoral
or radial approach by the Judkins technique. General patient characteristics are shown in
Table 2.
Relationship between MI Associated WDR12 Allele and Cardiac
Function
Malmö Preventive Project (MPP) started in the mid 1970s at the Malmö University Hospital,
Malmö, Sweden as a prospective population-based study [33]. Between 1974 and 1992 a total
of 33,346 men and women from the Malmö city area were recruited and screened for conven-
tional risk factors for all-cause mortality and cardiovascular disease (CVD). Briefly, specially
trained nurses performed the examinations in the morning. Participants were fasting overnight
prior to investigation. Height and weight were measured in light indoor clothing without
shoes. Blood samples were collected and biochemical parameters were analyzed by routine
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methods at the Department of Clinical Chemistry, Malmö University Hospital. Afterwards,
participants answered a questionnaire consisting of approximately 260 questions using a self-
administered computer program. The questions centered on personal and family history of
CVD (myocardial infarction and stroke), hypertension, diabetes and cancer, as well as on con-
ventional risk factors for these diseases. Antihypertensive treatment was defined as a positive
answer to the following question: Do you take medication for high blood pressure? Blood pres-
sure (BP) was measured in the supine position by specially trained nurses with a mercury
sphygmomanometer and an appropriate cuff placed around the right arm at the level of the
heart. In the years 2002–2006, all survivors from the original MPP cohort were invited to a fol-
low-up examination. Of these, 18,240 participants responded to the invitation and were re-ex-
amined [34]. There were no exclusion criteria and of those who were alive the participation
rate was 72%. For genetic studies, additional samples of peripheral venous blood were collected,
as the original MPP design did not encompass DNA analyses.
In a sub-sample of the MPP follow-up examination, 1792 participants underwent echocar-
diography on a separate visit. As described in the original publication [35], subjects undergoing
echocardiography were randomly selected from groups of glucometabolic status (normal fast-
ing glucose, impaired fasting glucose, new onset diabetes mellitus and prevalent diabetes melli-
tus), with oversampling of the groups with glucometabolic disturbances). All subjects were
studied in the left lateral decubital position. Conventional echocardiography/Doppler and tis-
sue Doppler imaging (TDI) were conducted with a 3V2c transducer (Acuson Sequoia, Moun-
tain View, CA, USA) or a S3 transducer (Sonos 5500 Philips, Andover, MA, USA). Parasternal
long- and short-axis, and apical four- and two-chamber views were used to evaluate cardiac di-
mensions and LVEF [36]. Diastolic heart function was defined according to European Society
of Cardiology guidelines [37] and we compared genotypic distribution of the previously myo-
cardial infarction associated WDR12 SNP rs6725887 [5] between subjects who had normal dia-
stolic function or only mild diastolic dysfunction (relaxation impairment) and those with
significant diastolic dysfunction (i.e. subjects displaying a pseudonormalization pattern or a re-
strictive pattern). Left atrial area, indexed for body surface area, was used as a continuous trait
for diastolic function. All analyses were performed offline without any knowledge of the
Table 2. LV tissue samples were obtained from explanted human hearts in patients with cardiomyop-
athy undergoing heart transplantation.
Patient A B C D
Age (years) 44.9 50.9 47.2 53.8
Diagnosis DCM HCM DCM ICM
Gender male male male male
LVEF (%) 15 20 30 14
LA diameter (mm) 41 58 46 47
LVEDD (mm) 91 60 75 67
LVESD (mm) 83 51 62 62
sPA (mm Hg) 29 39 n.d. 30
RAP (mm Hg) 5 5 n.d. 15
E/E' n.d. 10 n.d. 18
DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; ICM, ischemic cardiomyopathy; LVEF,
left ventricular ejection fraction; LA, left atria; EDD, end diastolic diameter of the left ventricle; ESD, end
systolic diameter of the left ventricle; sPA, systolic pulmonary artery pressure; RAP, right atrial pressure; n.
d., not determined.
doi:10.1371/journal.pone.0124907.t002
WRD12 and Cardiac Function
PLOS ONE | DOI:10.1371/journal.pone.0124907 April 27, 2015 9 / 32
subjects’ clinical status. Out of the 1792 subjects who underwent echocardiography, diastolic
function could be determined in 1636 subjects and left atrial size in 1681 subjects. DNA was
available and extracted from buffy coats with the use of QIAamp-96 spin blood kits (QIAGEN,
Stockholm, Sweden) from 1496/1636 and 1531/1681 subjects and the rs6725887 SNP was suc-
cessfully genotyped in 1394/1496 and 1436/1531 subjects using primers and probes which
were custom synthesized by Applied Biosystems (Foster City, CA, USA) according to standard
recommendations for the AB Prism 7900HT analysis system, and genotyped with polymerase
chain reaction-based TaqMan method [38]. Detailed clinical characteristics of the 1436 sub-
jects included in the genetic analyses of left atrial area are shown in Table 3.
Statistics
Results are expressed as mean±SEM. For statistical analyses, the data were first tested by using
the Shapiro-Wilk test for normality. Because all variables were normally distributed, statistical
significance was evaluated by 1-way ANOVA followed by a least significant difference (LSD)
post hoc test for multiple comparisons. The Student t test was used for comparison between 2
groups. A probability value of<0.05 was considered statistically significant.
Crude and age- and sex-adjusted logistic regression models were used to relate rs6725887ge-
notypes to a dichotomous dependent variable of diastolic dysfunction (presence of pseudonor-
malization pattern or restrictive pattern versus normal diastolic function or relaxation
impairment). In crude and age- and sex-adjusted linear regression models we related
rs6725887 genotypes to body surface normalized left atrial size and ejection fraction as a
continuous variable.
Results
Cardiac Overload InducesWDR12 Expression through Direct Myocyte
Stretch and p38 MAPK
Because WDR12 was associated with early-onset MI in GWAS studies [4,5], we first assessed
the effect of post-infarction remodeling process on LVWDR12 gene expression. In response to
MI induced by ligation of LAD in rats, WDR12 mRNA levels increased 2.2-fold (Fig 1A) and
WDR12 protein levels 1.6-fold (Fig 1B) at day 1. When the effect of pressure overload on LV
WDR12 expression was studied by infusing Ang II up to 2 weeks in rats, WDR12 mRNA levels
were significantly elevated at 6 hours (1.9-fold)(Fig 1C). To characterize the potential mecha-
nisms by which cardiac overload increases WDR12 expression, we employed an in vitro
Table 3. Clinical characteristics of the subjects included in the genetic analyses of left atrial area in
Malmö Preventive Project (MPP).
Risk factor (n = 1436) Average min—max
Age (years) 67.7 ± 5.7 56.8–79.9
Gender (% male) 71.2 -
Systolic blood pressure (mmHg) 147 ± 19.8 94.5–253
Diastolic blood pressure (mmHg) 84.3 ± 4.2 56–135
Use of antihypertensive medication (%) 47.7 -
Body mass index (kg/m2) 28.2 ± 4.2 17.6–52.9
LDL-cholesterol (mmol/L) 3.5 ± 1.0 0.6–7.3
HDL-cholesterol (mmol/L) 1.3 ± 0.40 0.18–3.5
Current smokers (%) 18.3 -
Diabetes (%) 25.7 -
doi:10.1371/journal.pone.0124907.t003
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mechanical stretch model of cultured cardiomyocytes [39]. As shown in Fig 1D, direct me-
chanical stretch augmented WDR12 gene expression in neonatal rat cardiomyocytes, peaking
at 12 h (2.6-fold). Moreover, once the role of the stretch-activated p38 MAPKs [25] in regulat-
ing WDR12 expression was studied, p38α but not p38β gene transfer in vitro increased
WDR12 mRNA levels 1.8-fold (Fig 1E). To examine the LV localization of WDR12 we used
immunofluorescence analysis with rat thymus [8] as a positive control. WDR12 was expressed
in cardiac myocytes of rat hearts at 1 day post-infarction (Fig 1F and 1G).
Fig 1. Induction of WDR12 expression by cardiac overload. A. Up-regulation of LVWDR12 mRNA, andB. protein levels by experimental MI at day 1 in
rats. Representative Western blots are shown. Bands were detected from the same gel. Results are expressed as mean±SEM (n = 11 to 16). **P<0.01 MI
(solid bars) versus sham (open bars) group (Student t test). C. Up-regulation of WDR12 mRNA levels in Ang II-induced hypertension at 6 hours. Results are
expressed as mean±SEM (n = 6 to 8). **P<0.01 Ang II (solid bars) versus control (open bars) group (Student t test). D. Increase of WDR12mRNA levels by
mechanical stretch (n = 5 to 6), and E. p38 MAPK gene transfer (n = 6) in vitro in cell culture. The results are expressed as mean±SEM. *P<0.05, **P<0.01
versus control-group (1-way ANOVA followed by LSD post hoc test). F. Immunofluorescence staining of LV anterior wall, andG. thymus at day 1 post-
infarction in rats. WDR12 is located in cardiac myocytes. WDR12 (green) and DAPI (blue).
doi:10.1371/journal.pone.0124907.g001
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Augmentation of LVWDR12 Levels by Adenoviral Gene Delivery
To study the direct myocardial effects of WDR12, we established an in vivo gene transfer proto-
col to locally increase LVWDR12 levels in the adult rat heart. As shown in Fig 2A, a dose-de-
pendent increase in WDR12 protein levels, measured by western blot, was noted at day 3 after
gene delivery. When WDR12 expressing adenoviral construct was injected into the LV free
wall at 4x109 ifu, WDR12 mRNA levels (Fig 2B) were highest at 1 week and protein levels (Fig
2C) at day 3 after injections and decreased thereafter to the levels of LacZ-treated hearts at 2
weeks. The increase in LVWDR12 protein levels at 1 week after gene delivery closely mimicked
those increases observed in rats post-infarction and in response to pressure overload (see Fig
Fig 2. Cardiac specific activation of WDR12 by adenoviral gene delivery into the LV. A. Different doses of WDR12 adenoviral constructs were tested to
increase LVWDR12 protein levels. Representative Western blots are shown. Bands were detected from the same gel. The results are expressed as mean
±SEM (n = 3). *P<0.05, **P<0.01 versus 1x109 IFU/rat injected group (1-way ANOVA followed by LSD post hoc test). B.WDR12mRNA levels measured by
RT-PCR, andC.WDR12 protein levels assessed byWestern Blot analyses from the tissue samples 3 days, 1 week and 2 weeks after WDR12 gene delivery.
Bands were detected from the same gel. Open bars represent LacZ and solid bars WDR12. The results are expressed as mean±SEM (n = 8 to 10). *P<0.05,
**P<0.01, ***P<0.001 versus LacZ (Student t test).D. Immunofluorescence staining of LV anterior wall at day 3 after gene transfer showingWDR12
predominantly in cardiomyocytes (WDR12, red).
doi:10.1371/journal.pone.0124907.g002
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1B and 1C). The efficiency and localization of the WDR12 gene delivery was further confirmed
by immunofluorescence. As shown in Fig 2D, immunofluorescence analysis showed augment-
ed local staining in the cardiomyocyte nuclei of WDR12-treated hearts compared to LacZ-
treated hearts.
Local Myocardial WDR12 Gene Delivery Deteriorates Cardiac Function
in Normal Adult Rats
The effect of WDR12 gene delivery on cardiac function was analyzed by echocardiography (Fig
3A through 3G and Table 4) at 1 week following gene transfer. WDR12 gene transfer in normal
rat hearts resulted in reduced interventricular septum thickness (Fig 3B and 3C) and increased
LV diameters (Fig 3D and 3E) in both diastole and systole. Moreover, WDR12 gene delivery
significantly decreased LVEF (P<0.05) and FS (P<0.05) (Fig 3F and 3G), collectively indicat-
ing that WDR12 gene delivery deteriorated cardiac function in normal adult rats.
Effects of WDR12 Gene Delivery Post-Infarction and in Angiotensin
II-Induced Hypertension
Because both MI and pressure overload caused significant up-regulation of WDR12 levels, we
next examined the effects of WDR12 gene transfer on LV function and structure in MI induced
by ligation of LAD and in angiotensin II-induced hypertension in rats. LVWDR12 mRNA and
protein levels at 1 and 2 weeks after WDR12 gene transfer post-infarction and in Ang II-medi-
ated hypertension increased similarly to those observed in normal adult rat hearts (Data not
shown). As assessed by echocardiography, LV dimensions, LVEF and FS of WDR12-treated
animals were similar to those of LacZ-treated hearts, while ligation of LAD alone caused a
marked decrease in LVEF and FS (Table 4). Likewise, WDR12 gene transfer did not significant-
ly affect LV dimensions, LVEF or FS in rats infused with Ang II (Table 4). However, evaluation
of diastolic function revealed that WDR12 gene transfer decreased E/A ratio by 32% (P<0.05)
at 1 week post-infarction (Fig 4A and 4B), suggesting that WDR12 gene delivery results in dia-
stolic dysfunction. There was also a non-significant decrease in E/A ratio in normal rat hearts
(13%) and in Ang II-mediated hypertension (27%)(Fig 4B). There was also a tendency towards
increased isovolumic relaxation time (IVRT) at 1 week (Fig 4C). Interestingly, consistently
with the impairment of cardiac function, LV SERCA2 protein levels were lower after WDR12
gene transfer at day 3 in normal adult rats, but remained unchanged in WDR12-treated hearts
post-infarction and in Ang II-mediated hypertension (Fig 5A through 5C). Furthermore,
SERCA2 mRNA levels decreased in response to adenoviral transfection of WDR12 in vitro in
rat neonatal cardiomyocytes and increased by cell-specific silencing of WDR12 (Fig 5D and
5E).
Marked Reduction of LV Cell Proliferation by WDR12 Overexpression
Since PeBoW complex regulates cell proliferation [9], we next assessed whether the changes in
cardiac structure and function after WDR12 gene delivery were related to the alterations in cell
proliferation by staining histological sections immuno-histochemically against nuclear Ki-67.
As shown in Fig 6A, intramyocardial WDR12 gene delivery resulted in a marked decrease
(75%) in the number of Ki-67 positive cells at 1 week. Double immunofluorescence staining of
proliferating cells showed that they were positive for fibroblast marker prolyl 4-hydroxylase
(Fig 6A) but not for cardiomyocyte or endothelial cell markers (Fig 7A and 7B). We also ana-
lyzed histological sections for apoptotic cell death, myocardial fibrosis, cardiac stem cell re-
cruitment and angiogenesis. As assessed by TUNEL assay, WDR12 gene transfer significantly
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decreased apoptotic cell death (65%)(Fig 6B). Double immunofluorescence staining of
TUNEL+ cells showed that also they were positive for fibroblast marker prolyl 4-hydroxylase
(Fig 6B) but not for cardiomyocyte or endothelial cell markers (Fig 7C and 7D). Moreover,
Fig 3. Intramyocardial WDR12 gene delivery deteriorates cardiac function in normal adult rat. Adenoviral construct expressingWDR12 and LacZ were
injected into LV free wall. Echocardiographic measurements were performed 1 week after gene transfer.A. Representative M-mode images are shown.
Treatment with WDR12 overexpressing vector significantly decreased interventricular septum diastolic (B) and systolic thickness (C), and increased LV
diastolic (D) and systolic diameters (E). Overexpression of WDR12 decreased LV ejection fraction (F) and fractional shortening (G). The results are
expressed as mean±SEM (n = 7 to 10). *P<0.05, **P<0.01 versus LacZ-control group (Student t test).
doi:10.1371/journal.pone.0124907.g003
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there was a non-significant increase in myocardial fibrosis, measured by staining histological
sections with Masson’s trichrome (Fig 6C), and a significant increase in LV expression of a fi-
brosis-related gene, fibronectin-1 (Fig 6D). On the other hand, the number of c-kit+ cells or
coronary angiogenesis did not significantly differ between LacZ- and WDR12-treated hearts
(Data not shown). Finally, because dominant-negative mutant of WDR12 has been shown to
block rRNA processing, induce a reversible cell cycle arrest, and trigger accumulation of p53 in
a p19ARF-independent manner in proliferating cells [9], we examined the effects of WDR12
gene delivery on the LV mRNA levels of selected regulators of the cell cycle. However, no sig-
nificant differences in cyclin-dependent kinase inhibitor 2b and 2c, p19ARF and p16INK4a
mRNA levels were observed between WDR12-treated and LacZ-treated normal rat hearts and
post-infarction at 1 week after gene transfer (Fig 8).
Table 4. Effect of intramyocardial WDR12 gene delivery on cardiac structure and function in normal adult rat hearts, post-infarction, and in angio-
tensin II-induced hypertension at 1 week.
Variable Group Normal heart MI Ang II
Interventricular septum thickness
diastole (mm) LacZ 2.2 ± 0.1 0.9 ± 0.1 2.1 ± 0.1
WDR12 1.9 ± 0.1* 1.2 ± 0.1** 2.2 ± 0.3
systole (mm) LacZ 3.0 ± 0.1 1.0 ± 0.1 3.0 ± 0.1
WDR12 2.6 ± 0.1* 1.3 ± 0.1 3.1 ± 0.4
LV diameter
diastole (mm) LacZ 7.5 ± 0.2 9.3 ± 0.2 7.3 ± 0.3
WDR12 8.1 ± 0.2* 9.2 ± 0.2 7.2 ± 0.3
systole (mm) LacZ 5.1 ± 0.2 8.1 ± 0.3 4.9 ± 0.3
WDR12 5.8 ± 0.1** 8.1 ± 0.2 4.6 ± 0.3
Posterior wall thickness
diatole (mm) LacZ 1.7 ± 0.1 1.6 ± 0.1 2.0 ± 0.1
WDR12 1.6 ± 0.1 1.6 ± 0.1 1.7 ± 0.2
systole (mm) LacZ 2.6 ± 0.1 2.1 ± 0.1 2.8 ± 0.1
WDR12 2.5 ± 0.1 2.2 ± 0.2 2.5 ± 0.1
LV ejection fraction (%)
LacZ 66.8 ± 1.6 31.9 ± 3.8 67.6 ± 3.9
WDR12 60.7 ± 1.8* 29.0 ± 3.7 69.7 ± 3.2
Fractional shortening (%)
LacZ 32.7 ± 1.2 13.4 ± 1.8 34.0 ± 2.8
WDR12 28.7 ± 1.2* 12.0 ± 1.7 35.5 ± 2.5
IVRT
LacZ 26.3 ± 1.0 27.4 ± 0.9 32.8 ± 1.2
WDR12 27.4 ± 1.4 28.4 ± 0.8 35.3 ± 2.1
E/A-ratio
LacZ 5.0 ± 0.5 7.3 ± 0.8 2.5 ± 0.4
WDR12 4.5 ± 0.4 5.0 ± 0.6* 1.8 ± 0.3
MI, myocardial infarction; Ang II, angiotensin II; LV, left ventricular; IVRT, isovolumic relaxation time
Adenoviral gene construct expressing WDR12 and LacZ were injected into LV free wall and echocardiographic measurements were performed at 1 week
after gene transfer. The results are expressed as mean±SEM (n = 7–10).
*P<0.05,
**P<0.01 vs LacZ (Student t test).
doi:10.1371/journal.pone.0124907.t004
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Regulation of BOP1 and Pes Protein Levels by WDR12
Because WDR12 forms a stable complex and directly interacts with nucleolar target genes Pes1
and BOP1 in rRNA processing and proliferation [40,41], we next examined protein levels of
BOP1 and Pes after WDR12 gene transfer by Western blot analysis. Remarkably, WDR12 over-
expression consistently increased BOP1 in normal adult rat hearts (P<0.05)(Fig 9A), post-in-
farction (P<0.05)(Fig 9C), in Ang II-induced hypertension (P<0.05)(Fig 9E) and in vitro in
neonatal rat cardiomyocytes (p = 0.061)(Fig 9G and Fig 10A and 10B) and in cardiac fibro-
blasts (Fig 11A and Fig 12A and 12B). Pes protein levels increased significantly by WDR12
gene transfer only at 1 week post-infarction (Fig 9B, 9D, 9F and 9H and Fig 11B). Moreover,
BOP1 and Pes protein levels were decreased after WDR12 siRNA transfection in both neonatal
cardiomyocytes (Fig 9I and 9J and Fig 10C and 10D) and fibroblasts (Fig 11C and 11D and Fig
12C and 12D).
WDR12 activates p38 MAPK/HSP27 and ERK1/2 Pathways
To further evaluate potential mechanisms triggering structural changes and LV dysfunction by
local WDR12 gene delivery, we assessed changes in the phosphorylations of p38 MAPK, ERK1/2
and HSP27, involved in regulation of cell proliferation, differentiation and survival [42,43].
WDR12 gene delivery significantly increased both p38 MAPK/HSP27 and ERK1/2 phosphoryla-
tions in the adult rat hearts at 1 week (Fig 13A through 13C). Up-regulation ofWDR12 levels
produced increase of p38 MAPK and HSP27 but not ERK1/2 phosphorylation also post-
infarction (Fig 13D through 13F). In Ang II-induced hypertension, WDR12 gene delivery signifi-
cantly increased both p38 MAPK and ERK1/2 phosphorylations and non-significantly HSP27
Fig 4. Intramyocardial WDR12 gene delivery decreases diastolic function in rats. Adenoviral construct
expressingWDR12 and LacZ were injected into LV free wall. Echocardiographic measurements were
performed 1 week after WDR12 gene transfer. A. Representative mitral flow velocity images of LacZ- and
WDR12-injected infarcted hearts are shown.B. E/A ratio decreased significantly by intramyocardial WDR12
gene transfer in infarcted hearts, and non-significantly in WDR12-treated normal hearts and Ang II-infused
hearts.C. IVRT values increased non-significantly by intramyocardial WDR12 gene transfer, in
WDR12-treated normal hearts, infarcted hearts and Ang II-infused hearts. The results are expressed as
mean±SEM (n = 7 to 10). *P<0.05 versus LacZ-control group (Student t test).
doi:10.1371/journal.pone.0124907.g004
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phosphorylation (Fig 13G through 13I). Finally, p38 MAPK, HSP27 and ERK1/2 phosphoryla-
tions were up-regulated after adenoviral transfection ofWDR12 in vitro in rat neonatal cardio-
myocytes (Fig 13J through 13L) and fibroblasts (Fig 14A, 14C and 14E) associated with a
17.8-fold increase inWDR12 mRNA and 8.6-fold increase inWDR12 protein levels in myocytes
(Fig 10A and 10B) and 4.5-fold increase inWDR12 mRNA and 5.2-fold increase inWDR12 pro-
tein levels in fibroblasts (Fig 12A and 12B). Furthermore, WDR12 siRNA gene silencing in vitro
resulted in decreased phosphorylation of p38 MAPK, HSP27 and ERK1/2 in neonatal myocytes
(Fig 13M, 13N and 13O and Fig 10C and 10D) and in fibroblasts (Fig 14B, 14D and 14F and Fig
12C and 12D).
Augmented LVWDR12 Expression in Patients with cardiomyopathy
WDR12 protein was also found to be expressed in the LV of control human hearts and in pa-
tients with cardiomyopathy (Fig 15A and 15B). Nuclear WDR12 protein levels were higher
(1.8-fold) in patients with cardiomyopathy than in control hearts (Fig 15B and 15C), and there
was also a non-significant increase (2.1-fold) in total WDR12 protein levels in patients with
cardiomyopathy when compared to control hearts (Fig 15A and 15C). Also WDR12 mRNA as
well as ANP and BNP mRNA levels were higher in patients with cardiomyopathy (Data not
shown).
Fig 5. SERCA2 expression after intramyocardial WDR12 gene transfer and after WDR12 gene
silencing. SERCA2 protein levels were assessed byWestern Blot analyses from the LV samples 3 days, 1
week and 2 weeks after WDR12 gene delivery in normal adult rats (A), 1 week after myocardial infarction (B)
and in angiotensin II (Ang II)-induced hypertension at 1 week (C) (n = 8 to 10). Bands were detected from the
same gel.D. SERCA2 mRNA levels after adenoviral transfection of WDR12 in vitro in rat neonatal
cardiomyocytes (n = 4). A. open bars represent LacZ and solid bars WDR12. *P<0.05, **P<0.01 versus
LacZ (Student t test). E. SERCA2mRNA levels after WDR12 siRNA transfection in rat neonatal
cardiomyocytes (n = 4). *P<0.05, **P<0.001 versus negative control (1-way ANOVA followed by LSD post
hoc test). The results are expressed as mean±SEM.
doi:10.1371/journal.pone.0124907.g005
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MI Associated WDR12 Allele Associates with Diastolic Dysfunction in
Humans
In a crude additive model, the MI associated allele of rs6725887 (minor allele) was significantly
associated with larger left atrial area/BSA (β-coefficient±SEM)(0.32±0.12, P = 0.006), which re-
mained significant after age and sex adjustment (0.28±0.12, P = 0.016)(Fig 15D). Presence of
significant diastolic dysfunction (pseudonormalization or restrictive pattern) was significantly
associated with the MI associated allele of rs6725887 in crude additive model (odds ratio, 95%
Fig 6. Myocardial cellular proliferation, apoptotic cell death and fibrosis in the LV after local WDR12
gene delivery at 1 week. A. Immunohistochemical staining against Ki-67 was performed to study the effect
of WDR12 gene transfer on cellular proliferation. The whole left ventricle was scanned and stained cells were
counted from high power fields (40x) choosing 5 hot spot areas in each sample. Immunofluorescence
staining showing that proliferating cells were cardiac fibroblasts (red, Phospho-histone-H3; green, Prolyl
4-hydroxylase β). B. The rate of apoptosis was assessed by TUNEL. Immunofluorescence staining showing
that apoptotic cells were cardiac fibroblasts (Red, TUNEL; green, Prolyl 4-hydroxylase β). C.Masson’s
trichrome staining was used to define area of fibrosis by computerized methods. The results are expressed
as mean±SEM (n = 4 to 5). D. Fibronectin-1 mRNA levels were increased 1 week after WDR12 gene delivery.
Open bars represent LacZ and solid bars WDR12. The results are expressed as mean±SEM (n = 8 to 10).
*P<0.05, **P<0.01 versus LacZ (Student t test).
doi:10.1371/journal.pone.0124907.g006
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confidence interval) (1.42, 1.10−1.83, P = 0.007) as well as after age and sex adjustment (1.38,
1.07−1.79, P = 0.013)(Fig 15E). The association remained significant after additional adjust-
ment for history of myocardial infarction (1.41, 1.09–1.82, P = 0.009). In contrast, there was no
significant association between rs6725887 and variation of systolic function (LVEF)
(P = 0.616).
Discussion
While recent genome-wide association studies have associated WDR12 with early-onset MI
and CAD in humans [4,5], nothing is known of the function of WDR12 in the heart. In the
present study we found that LVWDR12 expression was elevated in patients with cardiomyop-
athy, in rats post-infarction and in Ang II-mediated hypertension. By using local intramyocar-
dial adenovirus-mediated gene delivery, we provide in vivo evidence that WDR12
overexpression deteriorated LV systolic and diastolic function in adult rat heart. Moreover, MI
associated allele of WDR12 was associated with diastolic dysfunction in humans. Collectively,
these results demonstrate that WDR12 induces worsening of LV function and suggest WDR12
as a potential novel therapeutic target for treatment of failing hearts.
Cellular processes often depend on stable physical associations between proteins. WDR12, a
member of nucleolar PeBoW-complex, has been implicated in variety cellular processes such
as pre-RNA processing, signal transduction, cell division, cell cycle progression, apoptosis and
gene regulation [8–10]. A previous study has suggested that the BOP1/WDR12 subcomplex is
retained in the cytoplasm, whereas BOP1/Pes1 is located in the nucleolus [10]. In addition, it
has been reported that cytoplasmic Pes1, BOP1 andWDR12 are unstable and that BOP1 re-
quires Pes1 for nucleolar transport [10]. Yet, the same researchers have found that overex-
pressed WDR12 is mainly located in the nucleolus [9], suggesting that nucleolar transport of
Fig 7. Immunofluorescence staining showing that proliferating cells and apoptotic cells were non-
cardiomyocytes and non-endothelial cells. A. Proliferating cells (red, Phospho-histone-H3; green, α-
actinin).B. Proliferating cells (red, Phospho-histone-H3; green, Pecam-1).C. Apoptotic cells (red, TUNEL,
green, α-actinin), D. Apoptotic cells (red, TUNEL, green, Pecam-1).
doi:10.1371/journal.pone.0124907.g007
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WDR12 also occurs independently of Pes1 and BOP1 proteins and that PeBoW complex as-
sembles in the nucleolus. In our present study, nuclear WDR12 protein levels were elevated in
LV of patients with cardiomyopathy, and there was also a non-significant increase in total
WDR12 protein levels. Moreover, while WDR12 overexpression in vivo resulted in local
Fig 8. Effects of WDR12 gene delivery on the expression of putativeWDR12 target genes in normal rat
heart and during 1 week post-infarction. A. Cyclin-dependent kinase inhibitor 2 b (Cdkn2b), B. Cdkn2c,C.
p19ARFexon1b,D. p16INK4a mRNA levels in normal rat heart and E. Cdkn2b, F. Cdkn2c,G.
p19ARFexon1b,H. p16INK4a mRNA levels at 1 week post infarction. A-D. Open bars represent LacZ and
solid bars WDR12. The results are expressed as mean±SEM (n = 7–10). P = ns versus LacZ (Student t test).
doi:10.1371/journal.pone.0124907.g008
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staining in the cardiomyocyte nuclei, high levels of WDR12 cytoplasmic protein were also ob-
served demonstrating the presence of both nucleolar and cytoplasmic WDR12 expression, and
that, at least partially, cytoplasmic WDR12 is also stable in myocytes. Of note, the transient ex-
pression of WDR12 protein might be a consequence of post-translational modification of over-
expressed protein or neutralizing antibodies. Indeed, several previous studies have reported
that the immunogenicity of transgene proteins is a primary determinant of the temporal trans-
gene expression [44–46].
The present study shows that LVWDR12 mRNA and protein levels increase rapidly in re-
sponse to cardiac overload (within 6–24 hours) suggesting that WDR12 may have a role in an
early-phase remodeling process post-infarction and in pressure overload in rats. Further char-
acterization of the role of cardiomyocytes in cardiac overload-inducedWDR12 gene expression
revealed that stretching of cultured neonatal myocytes resulted in up-regulation of WDR12
mRNA levels. In cardiac myocytes, mechanical stretch induces the MAPK cascade, resulting in
Fig 9. Effects of intramyocardial WDR12 gene delivery andWDR12 gene silencing on BOP1 and Pes
nuclear protein expressions. A. BOP1, andB. Pes protein expression increased in normal rat hearts 1
week after gene transfer. C. BOP1, andD. Pes proteins were up-regulated byWDR12 gene transfer in
infarcted hearts. E. BOP1 protein expression increased in Ang II-induced hypertension, but no differences in
Pes protein level was noted (F).G. andH. BOP1 and Pes protein levels after adenoviral transfection of
WDR12 in vitro in rat neonatal cardiomyocytes. The results are mean±SEM (n = 7 to 10). *P<0.05 versus
LacZ-control group (Student t test). I. and J. BOP1 and Pes protein levels after WDR12 siRNA transfection in
rat neonatal cardiomyocytes (n = 4). *P<0.05, **P<0.01 versus negative control (1-way ANOVA followed by
LSD post hoc test). Representative Western blots are shown. Bands were detected from the same gel.
doi:10.1371/journal.pone.0124907.g009
Fig 10. Activation and silencing of WDR12 in rat neonatal cardiac myocytes in vitro. A.WDR12 mRNA
levels measured by RT-PCR, andB.WDR12 protein levels assessed byWestern Blot analyses from total
protein cell lysates 48 hours after WDR12 gene transfer (n = 8). ***P<0.001 versus LacZ-group (Student t
test). C.WDR12mRNA andD. WDR12 protein levels after WDR12 siRNA transfection (n = 4). **P<0.01,
***P<0.001 versus negative control group (1-way ANOVA followed by LSD post hoc test). The results are
expressed as mean±SEM. Representative Western blots are shown. Bands were detected from the
same gel.
doi:10.1371/journal.pone.0124907.g010
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Fig 11. Effects of WDR12 gene delivery andWDR12 gene silencing in vitro in rat neonatal fibroblasts.
A. BOP1 andB. Pes protein levels after adenoviral transfection of WDR12. *P<0.05 versus LacZ-control
group.C. BOP1 andD. Pes protein levels after WDR12 siRNA transfection *P<0.05, **P<0.01 versus
negative control group (1-way ANOVA followed by LSD post hoc test). The results are mean±SEM (n = 4).
Representative Western blots are shown. Bands were detected from the same gel.
doi:10.1371/journal.pone.0124907.g011
Fig 12. Activation and silencing of WDR12 in rat neonatal cardiac fibroblasts in vitro. A.WDR12 mRNA
levels measured by RT-PCR, andB.WDR12 protein levels assessed byWestern Blot analyses from total
protein cell lysates after WDR12 gene transfer. ***P<0.001 versus LacZ-group (Student t test). C.WDR12
mRNA andD.WDR12 protein levels after WDR12 siRNA transfection (n = 4). *P<0.05, **P<0.01,
***P<0.001 versus negative control group (1-way ANOVA followed by LSD post hoc test). The results are
expressed as mean±SEM (n = 4). Representative Western blots are shown. Bands were detected from the
same gel.
doi:10.1371/journal.pone.0124907.g012
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the activation of three terminal MAP kinases, p38 kinase, ERK and c-jun N-terminal protein
kinase [25,42]. Since p38α but not p38β gene transfer in vitro increased WDR12 mRNA levels,
our results suggest that cardiac overload induces WDR12 expression in the heart via p38α
MAPK activation induced by direct mechanical myocyte stretch (Fig 16). Of note, both post-
infarction remodeling and Ang II-induced hypertension involve early cardiac activation of p38
MAPK [42].
A key finding of our present study was that in normal adult rat hearts WDR12 gene delivery
into the anterior wall of the LV decreased interventricular septum diastolic and systolic thick-
ness and increased diastolic and systolic diameters of the LV. Moreover, LVEF and FS were re-
duced indicating deteriorated systolic function. It is noteworthy that changes in LVEF and FS
as well diameters of the LV and septum thickness by WDR gene delivery were similar in mag-
nitude than those produced by the 2 weeks angiotensin II infusion [27], indicating that the
changes in cardiac function and structure were physiologically relevant. However, WDR12
gene delivery did not affect LV systolic function post-infarction or in Ang II-mediated hyper-
tension. Likewise, SERCA2 protein levels remained unchanged in WDR12-treated hearts post-
infarction and in Ang II-mediated hypertension, whereas WDR12-induced impairment of LV
systolic function was associated with the reduction of SERCA2 expressions in normal hearts.
Collectively these results using different experimental animal models indicate that myocardial
WDR12 modulates cardiac function through context- and disease-dependent mechanisms.
The mechanisms for these distinct cardiac actions of WDR12 remain to be established, but
may be due to diverse pathophysiological processes in MI and hypertension-induced heart dis-
ease [2,3]. Nonetheless, these context-dependent effects appear not to be unique for WDR12.
For example, BNP [27] and p38 MAPK [13,14] gene transfers under identical experimental
conditions showed distinct context-dependent effects on cardiac function and structure.
Because WDR12 gene delivery resulted in consistent elevation of BOP1 protein levels in
normal adult rat hearts and post-infarction, and in Ang II-induced hypertension, but Pes1 pro-
tein levels were unaltered or increased only slightly, BOP1 may mainly mediate the distinct ef-
fects of WDR12 on cardiac function. BOP1 has a crucial role in PeBoW homeostasis and
increased levels of BOP1 induces BOP1/WDR12 and BOP1/Pes1 subcomplexes and the assem-
bly of the PeBoW complex is highly sensitive to changes of BOP1 protein levels [10]. Moreover,
loss of WDR12 has no detectable effect on Pes1 expression levels, whereas reduction of BOP1
destabilized Pes1, thus showing that the interaction of Pes1 and WDR12 may be indirect and
mediated by BOP1 [10]. Therefore, one possibility is that Pes1 protein expression remained
largely unchanged after WDR12 gene delivery due to this indirect interaction between Pes1
andWDR12. Of note, an earlier study has reported that enforced expression of HA-tagged
BOP1 was partially compensated by a decrease in endogenous BOP1, thus indicating that en-
dogenous BOP1 expression within a cell is highly controlled [10]. Taking this into account, it
might be that endogenous WDR12 expression was also partially decreased after WDR12
gene delivery.
The adverse effects of WDR12 gene delivery on LV systolic function in normal rat hearts
were associated with the decreased cellular proliferation. Double immunofluorescence staining
Fig 13. Regulation of p38 MAPK, HSP27 and ERK1/2 phosphorylations byWDR12. A. andB. p38 MAPK and HSP27 phosphorylations were up-
regulated in normal heart,D. and E. after infarction, andG. andH. p38 MAPK in Ang II-induced hypertension at 1 week after WDR12 gene delivery.C. ERK1/
2 phosphorylations were up-regulated in normal heart at 3 days, and I. in Ang II-induced hypertension at 1 week, but not post-infarction (F). J. K. and L. p38
MAPK, HSP27 and ERK1/2 phosphorylations were increased by adenoviral transfection of WDR12 in vitro in rat neonatal cardiomyocytes (n = 7 to 10). A-C.
open bars represent LacZ and solid bars WDR12. *P<0.05, **P<0.01, ***P<0.001 versus LacZ-control group (Student t test).M. N. andO. p38 MAPK,
HSP27 and ERK1/2 phosphorylations were decreased byWDR12 siRNA transfection in vitro in rat neonatal cardiomyocytes (n = 4). *P<0.05 versus
negative control group (1-way ANOVA followed by LSD post hoc test). The results are mean±SEM. Representative Western blots are shown. Bands were
detected from the same gel.
doi:10.1371/journal.pone.0124907.g013
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Fig 14. Regulation of p38 MAPK, HSP27 and ERK1/2 phosphorylation byWDR12 in vitro in rat neonatal cardiac fibroblasts. A. C. and E. p38 MAPK,
HSP27 and ERK1/2 phosphorylations were increased by adenoviral transfection of WDR12. *P<0.05, ***P<0.001 versus LacZ-control group (Student t
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showed that proliferating cells were cardiac fibroblasts. As discussed above, PeBoW complex is
essential for cell proliferation and maturation of the large ribosomal subunit [9,10,40,41]. It has
been reported that depletion of endogenous WDR12 inhibited cell proliferation, suggesting
that inhibition of pre-rRNA processing is coupled with repression of cell proliferation [9]. On
test). B. D. and F. p38 MAPK, HSP27 and ERK1/2 phosphorylations were decreased byWDR12 siRNA transfection in vitro in rat neonatal cardiac
fibroblasts. *P<0.05, **P<0.01 versus negative control group (1-way ANOVA followed by LSD post hoc test). The results are mean±SEM (n = 4).
Representative Western blots are shown. Bands were detected from the same gel.
doi:10.1371/journal.pone.0124907.g014
Fig 15. WDR12 protein levels in human LVs and association of MI associated variant with
echocardiographic parameters. Representative Western blots are shown.A. WDR12 total protein andB.
WDR12 nuclear protein levels in patients with cardiomyopathy and donor control hearts. Bands were
detected from the same gel.C. WDR12 protein levels relative to donor control hearts. The results are
expressed as mean±SEM. *P<0.05 versus control group (Student t test). D. Left atrial area/BSA (cm2/m2) in
carriers of the previously myocardial infarction associated rs6725887WDR12 genotypes and E. odds ratio
(95% confidence intervals) for diastolic dysfunction (pseudonormalization + restrictive versus normal +
relaxation impairment) in carriers of the previously myocardial infarction associated rs6725887WDR12
genotypes.
doi:10.1371/journal.pone.0124907.g015
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the other hand, in vitro overexpression of BOP1 but not WDR12 and Pes1 inhibited cell prolif-
eration and rRNA processing [10]. It is also notable that BOP1 seems to be a part of larger ribo-
some-associated complex than PeBoW containing 9 or more subunits including GATA
transcription factors activator GNL3 [47] and that the integrity of the PeBOW complex is
tightly controlled by protein-protein interactions and highly sensitive to elevated levels of
BOP1 [10]. Therefore, we hypothesize that in our study WDR12 interaction with BOP1 re-
sulted in decreased fibroblast proliferation, leading to thinning of LV wall, LV dilatation and
LV cardiac dysfunction. Nevertheless, in view of the context-dependent actions, it is funda-
mental in further studies to decipher the protein complexes performing many of the diverse ac-
tivities of WDR12 to cell homeostasis and proliferation.
Strikingly, WDR12 gene delivery also affected LV diastolic function, as reflected by signifi-
cantly decreased E/A ratio post-infarction. In agreement with this, in human subjects the MI
associated rs6725887 WDR12 variant was associated with LV diastolic dysfunction and in-
creased left atrial size, suggesting that WDR12 is of importance for LV diastolic function also
in humans. The fact that WDR12 gene transfer adversely affected LV diastolic function in the
rat heart and that WDR12 was up-regulated in failing human hearts suggests that the MI asso-
ciated allele of WDR12 leads to up-regulation of WDR12 expression and diastolic dysfunction
Fig 16. A schematic presentation of WDR12 in the heart.Our results suggest that in MI increased LV wall
tension induces up-regulation of WDR12 expression via direct myocyte stretch and activation of p38 MAPK
pathway. WDR12 gene delivery activated BOP1 and p38 MAPK/HSP27 pathways, leading to decreased cell
proliferation and pro-fibrosis, thinning of the LV wall and dilatation of the LV, and myocardial dysfunction.
doi:10.1371/journal.pone.0124907.g016
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in humans. As the human MI associated allele does not alter the predicted WDR12 amino acid
sequence, the gene variant (or a nearby SNP in linkage disequilibrium with it) most likely ex-
erts its effects through altered WDR12 expression levels. Further, although LV diastolic dys-
function is generally thought to be a result of rather than a risk factor for CAD, their strong co-
occurrence [48] suggests that genetically WDR12 mediated risk of LV diastolic dysfunction
may partially explain why WDR12 gene variance is associated with MI. Interestingly, although
WDR12 genetic variance is strongly associated with MI, the association with diastolic dysfunc-
tion was independent of previous MI. Still, despite being statistically independent, we cannot
exclude that the association we observe in humans could be a consequence of coronary heart
disease, especially since knock-down of WDR12 has been shown to affect cholesterol metabo-
lism [49]. On the other hand, no GWAS has so far identified genome-wide significant evidence
for association between WDR12 variance and heart failure [50,51].
The pathogenic mechanisms underlying diastolic HF are incompletely understood, but
comprise changes in LV myocardial structure, cardiomyocyte function, myofilamentary pro-
teins and fibrosis in particular [52]. Since p38 MAPK overexpression causes cardiac fibrosis
and depresses cardiac contractility [14], the activation of p38 MAPK pathway by WDR12 gene
delivery may be linked to pro-fibrotic response and cardiac dysfunction (Fig 16). In addition,
the decreased apoptotic cell death in the normal heart could be a consequence of HSP27 activa-
tion, as HSP27 can inhibit apoptosis caused by various stimuli [43]. Notably, while both fibro-
blast proliferation and the rate of apoptosis declined, proportionally the reduction in fibroblast
proliferation was somewhat larger in accordance with the thinning of the LV and a tendency
towards increased fibrosis by WDR12 gene delivery. It is also noteworthy that changes in LV
systolic function, cell proliferation and apoptosis were context-dependent, but the activation of
p38/HSP27 pathway, up-regulation of BOP1 levels and decrease in E/A ratio (or tendency for
it) by WDR gene overexpression, were not. Overall, in the present study we could study struc-
tural and functional changes during the early remodeling process, because adenoviral gene de-
livery results in transient increase in WDR12 expression. Therefore, to study the longer-term
effects on cardiac structure, function and mortality, detailed experiments in other models
are needed.
Despite optimal treatment with the existing drugs, the prognosis of systolic HF remains
poor. Moreover, to date, there is no proven effective therapy specifically for diastolic HF. Ap-
proximately half of the patients with HF have diastolic dysfunction with preserved LVEF [53].
The prevalence of HF with preserved LVEF in the community is increasing and is associated
with an exceedingly high mortality [54]. Our present results indicate that local WDR12 gene
delivery in rats has adverse effects on systolic and diastolic function. In particular, since MI as-
sociated WDR12 allele was associated with diastolic dysfunction, therapeutic strategies de-
signed to specifically modulate WDR12 might represent a promising new approach to treat
patients with diastolic HF.
Limitations
A limitation of adenovirus-mediated gene delivery is that adenovirus infection may lead to a
dose-dependent inflammatory reaction followed by cell death [55]. Hence, the virus dose needs
to be optimized to maintain normal cell function and survival. In our earlier study under iden-
tical experimental conditions, the number of infiltrating cells in adenoviral-injected hearts was
similar to that in LacZ-treated normal hearts and in hearts post-infarction [27]. Another po-
tential limitation is that adenovirus specific and neutralizing antibodies might be generated
against the transgene product [55].
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